Korean J Urol.
1999 Dec;40(12):1728-1729.
A Case of Intracavernous Needle Breakage during Intracavernous Self-injection of Prostaglandin E1 ( Caverject? )
- Affiliations
-
- 1Department of Urology, Dongkang Hospital, Ulsan, Korea.
Abstract
- Intracavernous self-injection of vasoactive agents for the treatment of erectile dysfunction has been used widespread in recent years. Complications of intracavernous self-injection include priapism, burning sensation, fibrosis, penile nodule and urethral injection. We report a case of intracavernous needle breakage associated with the Prostaglandin E1 self-injection therapy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Intracorporeal Needle Breakage during Intracavernous Self-injection of Vasoactive Agent: A Case Report
- Intracavernosal Needle breakage developed during Self-injection of Vasoactive Agent : Two case reports
- Erectile Response to Intracavernous Injection of Prostaglandin E1 or Papaverine in Impotence Patients with Diabetes Mellitus
- Are There Clinical Factors Relating to Penile Pain associated with Intracavernous Injection of Prostaglandin E1 in Patients with Erectile Dysfunction?
- Prostaglandin E1 Monotherapy for Impotence
